Dupilumab 300Mg Solution for Injection

DRUG2 trials

Sponsors

University of Cologne, Mayo Clinic

Conditions

Localized SclerodermaPruritus

Phase 2

Clinical Trial to Evaluate Efficacy and Safety of Dupilumab in Localized Scleroderma

CompletedNCT04200755

University of CologneLocalized Scleroderma

Start: 2020-05-19End: 2023-11-30Updated: 2024-10-26

Dupilumab for the Treatment of Moderate to Severe Chronic Hepatic Pruritus

CompletedNCT04256759

Mayo ClinicPruritus

Start: 2020-09-01End: 2024-09-06Updated: 2025-11-21